Seftri-S 250mg/125mg Injection
Marketer
Injecto Capta Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Seftri-S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be strictly under medical guidance; complete the prescribed course regardless of symptom improvement, as premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; intensified effects necessitate immediate medical consultation. Allergic reactions (rash, pruritus, edema, dyspnea) require emergency attention. Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Monitoring may include laboratory and diagnostic tests to assess treatment response.
Uses of Seftri-S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Seftri-S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Seftri-S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Seftri-S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Seftri-S 250mg/125mg Injection works:
Seftri-S injection, containing 250mg of Ceftriaxone and 125mg of Sulbactam, combines an antibiotic with a resistance-reducing agent. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial defenses, thereby augmenting Ceftriaxone's antimicrobial effect.
SAFETY ADVICE
AlcoholSAFE
Seftri-S 250mg/125mg Injection concurrent with alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Seftri-S 250mg/125mg is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or absent harm to offspring; however, data from human studies are scarce.
Breast feedingCAUTION
The administration of Seftri-S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Mothers should temporarily discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Seftri-S 250mg/125mg Injection can potentially reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Operating a vehicle should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Seftri-S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Seftri-S 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Seftri-S 250mg/125mg Injection is unnecessary in patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Seftri-S 250mg/125mg Injection :
Should you inadvertently skip a scheduled dose of Seftri-S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Seftri-S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
3,018 People bought this recently